Analyst Rating Changes — Upgrades, Downgrades & Price Targets

46577 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

WhenStockChange FirmAnalyst RatingPrice Target
Sep 09
09:57 UTC
JSG
Johnson Service Group
◎ Target Berenberg Bank firm only Buy GBX 205→ GBX 200-2.4%
Sep 09
09:57 UTC
DNLM
Dunelm Group
◎ Target JPMorgan Chase & Co. firm only Overweight GBX 1,225→ GBX 1,050-14.3%
Sep 09
09:57 UTC
CCC
Computacenter
◎ Target Berenberg Bank firm only Buy GBX 5,300→ GBX 6,500+22.6%
Sep 09
09:57 UTC
SGMT
Sagimet Biosciences
↑ Upgrade Barclays firm only Overweight
Sep 09
09:57 UTC
BETR
Better Home & Finance
↑ Upgrade CLSA firm only Buy
Sep 09
00:56 UTC
ZS
Zscaler
◎ Target Citigroup Fatima Boolani ★★★☆☆ #1342 Buy $175.00→ $205.00+17.1%
Sep 09
00:56 UTC
XPO
XPO
◎ Target Citigroup Ariel Rosa ★★☆☆☆ #2742 Neutral $221.00→ $220.00-0.5%
Sep 09
00:56 UTC
VRSK
Verisk Analytics
◎ Target Barclays Manav Patnaik ★★★☆☆ #2207 Overweight $275.00→ $225.00-18.2%
Sep 09
00:56 UTC
VLY
Valley National Bancorp
◎ Target Morgan Stanley Manan Gosalia ★★★☆☆ #2083 Equal Weight $16.00→ $17.00+6.2%
Sep 09
00:56 UTC
VLO
Valero Energy
◎ Target UBS Group Manav Gupta ★★★★☆ #797 Buy $355.00→ $450.00+26.8%
Sep 09
00:56 UTC
VERA
Vera Therapeutics
◎ Target JPMorgan Chase & Co. Anupam Rama ★★★☆☆ #1866 Overweight $76.00→ $83.00+9.2%
Sep 09
00:56 UTC
UMBF
UMB Financial
◎ Target Morgan Stanley Brian Wilczynski ★★☆☆☆ #2514 Overweight $159.00→ $190.00+19.5%
Sep 09
00:56 UTC
UDR
United Dominion Realty Trust
◎ Target Mizuho Vikram Malhorta not yet tracked Neutral $41.00→ $39.00-4.9%
Sep 09
00:56 UTC
TRI
Thomson Reuters
◎ Target Barclays Manav Patnaik ★★★☆☆ #2207 Overweight $140.00→ $130.00-7.1%
Sep 09
00:56 UTC
TH
Target Hospitality
◎ Target Oppenheimer Scott Schneeberger ★★★☆☆ #1124 Outperform $24.00→ $27.00+12.5%
Sep 09
00:56 UTC
TARS
Tarsus Pharmaceuticals
◎ Target Jefferies Financial Group Anthony Petrone ★★★★☆ #858 Buy $88.00→ $105.00+19.3%
Sep 09
00:56 UTC
SYM
Symbotic
◎ Target Barclays Guy Hardwick ★★★☆☆ #1939 Underweight $44.00→ $38.00-13.6%
Sep 09
00:56 UTC
STAN
Standard Chartered
◎ Target JPMorgan Chase & Co. firm only Overweight GBX 2,330→ GBX 2,470+6.0%
Sep 09
00:56 UTC
SPCX
SpaceX
◎ Target Wells Fargo & Company Ken Gawrelski ★★★☆☆ #2147 Overweight $215.00→ $212.00-1.4%
Sep 09
00:56 UTC
SNX
TD SYNNEX
◎ Target Barclays Guy Hardwick ★★★☆☆ #1939 Equal Weight $278.00→ $287.00+3.2%
Sep 09
00:56 UTC
SLG
SL Green Realty
◎ Target Barclays Brendan Lynch ★★★☆☆ #1751 Equal Weight $52.00→ $54.00+3.8%
Sep 09
00:56 UTC
SAIC
Science Applications International
◎ Target The Goldman Sachs Group Gavin Parsons ★★★☆☆ #2133 Sell $93.00→ $103.00+10.8%
Sep 09
00:56 UTC
SAIA
Saia
◎ Target Citigroup Ariel Rosa ★★☆☆☆ #2742 Buy $423.00→ $417.00-1.4%
Sep 09
00:56 UTC
RRC
Range Resources
◎ Target Barclays Betty Jiang ★★☆☆☆ #2789 Equal Weight $40.00→ $42.00+5.0%
Sep 09
00:56 UTC
RPRX
Royalty Pharma
◎ Target TD Cowen Michael Nedelcovych ★★★☆☆ #1587 Buy $65.00→ $68.00+4.6%
Sep 09
00:56 UTC
ROIV
Roivant Sciences
◎ Target Jefferies Financial Group Dennis Ding ★★★☆☆ #1892 Buy $42.00→ $52.00+23.8%
Sep 09
00:56 UTC
ROIV
Roivant Sciences
◎ Target HC Wainwright Douglas Tsao ★★☆☆☆ #2436 Buy $41.00→ $47.00+14.6%
Sep 09
00:56 UTC
RF
Regions Financial
◎ Target Morgan Stanley Betsy Graseck not yet tracked Equal Weight $35.00→ $36.00+2.9%
Sep 09
00:56 UTC
PTON
Peloton Interactive
◎ Target UBS Group Arpine Kocharyan ★★☆☆☆ #2359 Buy $11.00→ $10.00-9.1%
Sep 09
00:56 UTC
PSX
Phillips 66
◎ Target UBS Group Manav Gupta ★★★★☆ #797 Buy $235.00→ $300.00+27.7%
Sep 09
00:56 UTC
PGNY
Progyny
◎ Target Citizens Jmp Constantine Davides ★★★☆☆ #1304 Market Outperform $31.00→ $33.00+6.5%
Sep 09
00:56 UTC
ONTO
Onto Innovation
◎ Target Morgan Stanley Shane Brett not yet tracked Overweight $383.00→ $360.00-6.0%
Sep 09
00:56 UTC
NOW
ServiceNow
◎ Target BTIG Research Allan Verkhovski ★★★☆☆ #1175 Buy $150.00→ $170.00+13.3%
Sep 09
00:56 UTC
NOC
Northrop Grumman
◎ Target UBS Group Gavin Parsons ★★★☆☆ #2133 Buy $685.00→ $704.00+2.8%
Sep 09
00:56 UTC
MSTR
Strategy
◎ Target Canaccord Genuity Group Joseph Vafi ★★★☆☆ #1852 Buy $175.00→ $179.00+2.3%
Sep 09
00:56 UTC
MRK
Merck & Co., Inc.
◎ Target Guggenheim Vamil Divan ★★☆☆☆ #2518 Buy $146.00→ $170.00+16.4%
Sep 09
00:56 UTC
MPC
Marathon Petroleum
◎ Target UBS Group Manav Gupta ★★★★☆ #797 Buy $321.00→ $450.00+40.2%
Sep 09
00:56 UTC
MANH
Manhattan Associates
◎ Target Barclays Guy Hardwick ★★★☆☆ #1939 Overweight $201.00→ $239.00+18.9%
Sep 09
00:56 UTC
MAA
Mid-America Apartment Communities
◎ Target Mizuho Haendel St. Juste ★★★☆☆ #1702 Outperform $152.00→ $140.00-7.9%
Sep 09
00:56 UTC
JBL
Jabil
◎ Target The Goldman Sachs Group Mark Delaney ★★★☆☆ #2184 Buy $482.00→ $375.00-22.2%
Sep 09
00:56 UTC
IRM
Iron Mountain
◎ Target Barclays Brendan Lynch ★★★☆☆ #1751 Overweight $143.00→ $144.00+0.7%
Sep 09
00:56 UTC
IONS
Ionis Pharmaceuticals
◎ Target The Goldman Sachs Group Salveen Richter ★★★☆☆ #1856 Neutral $69.00→ $56.00-18.8%
Sep 09
00:56 UTC
IONS
Ionis Pharmaceuticals
◎ Target Morgan Stanley Michael Ulz ★☆☆☆☆ #2995 Overweight $110.00→ $104.00-5.5%
Sep 09
00:56 UTC
IONS
Ionis Pharmaceuticals
◎ Target HC Wainwright Mitchell S. Kapoor not yet tracked Buy $115.00→ $100.00-13.0%
Sep 09
00:56 UTC
IONS
Ionis Pharmaceuticals
◎ Target Canaccord Genuity Group Gary Nachman ★★☆☆☆ #2781 Buy $95.00→ $85.00-10.5%
Sep 09
00:56 UTC
HYPD
Hyperion DeFi
◎ Target Chardan Capital James McIlree ★☆☆☆☆ #2985 Buy $7.30→ $8.45+15.8%
Sep 09
00:56 UTC
HOOD
Robinhood Markets
◎ Target Cantor Fitzgerald Ramsey El-Assal not yet tracked Overweight $115.00→ $150.00+30.4%
Sep 09
00:56 UTC
HOOD
Robinhood Markets
◎ Target The Goldman Sachs Group James Yaro ★★☆☆☆ #2576 Buy $124.00→ $142.00+14.5%
Sep 09
00:56 UTC
HOOD
Robinhood Markets
◎ Target Jefferies Financial Group Daniel Fannon ★★★★☆ #408 Buy $127.00→ $140.00+10.2%
Sep 09
00:56 UTC
HOG
Harley-Davidson
◎ Target Citigroup James Hardiman ★★☆☆☆ #2460 Neutral $27.00→ $31.00+14.8%
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 321 / 932 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.